tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
enGene announves common shares offering, no amount given
PremiumThe FlyenGene announves common shares offering, no amount given
16d ago
enGene price target raised to $19 from $18 at Morgan Stanley
Premium
The Fly
enGene price target raised to $19 from $18 at Morgan Stanley
16d ago
enGene price target raised to $33 from $30 at Oppenheimer
Premium
The Fly
enGene price target raised to $33 from $30 at Oppenheimer
17d ago
Midday Fly By: SoftBank exits Nvidia, CoreWeave cuts guidance
PremiumThe FlyMidday Fly By: SoftBank exits Nvidia, CoreWeave cuts guidance
17d ago
Promising Advancements in enGene Holdings’ Clinical Trials Justify Buy Rating
Premium
Ratings
Promising Advancements in enGene Holdings’ Clinical Trials Justify Buy Rating
17d ago
enGene Holdings Inc trading resumes
Premium
The Fly
enGene Holdings Inc trading resumes
17d ago
enGene’s Detalimogene Shows Promising Results in Bladder Cancer Trial
PremiumCompany AnnouncementsenGene’s Detalimogene Shows Promising Results in Bladder Cancer Trial
17d ago
Buy Rating for enGene Holdings Amid Anticipated Positive Data from Phase 2 LEGEND Study
Premium
Ratings
Buy Rating for enGene Holdings Amid Anticipated Positive Data from Phase 2 LEGEND Study
18d ago
enGene to Discuss New Data from LEGEND Trial for Bladder Cancer Therapy
Premium
Company Announcements
enGene to Discuss New Data from LEGEND Trial for Bladder Cancer Therapy
18d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100